Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC00351, or long intergenic non-protein coding RNA 351, is a human gene that generates a non-coding RNA transcript over 200 nucleotides in length. This type of RNA is not translated into a protein but instead plays diverse roles in regulating gene expression, chromatin remodeling, and maintaining genomic architecture. LINC00351 belongs to the class of long intergenic non-coding RNAs (lincRNAs), which often function in a tissue-specific manner to fine-tune neighboring gene activity through multiple mechanisms. Although lincRNAs as a group have been implicated in various cellular and disease processes, no validated, direct functional or disease-specific associations are currently reported for LINC00351[1][5][7][9][13][15]. There is no evidence that LINC00351 acts as a conventional therapeutic target (such as a receptor, enzyme, transporter, or transcription factor). It is also not commonly associated with biomarkers, specific drugs, or direct safety concerns; its classification is strictly as a long intergenic non-coding RNA, primarily involved in regulation at the RNA level.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 351 (LINC00351).